Contact Glow Savannah today to schedule your semaglutide consultation and learn more about joining the Glow Health Club
This understanding allows for a personalized approach to treatment
Semaglutide is a type of medication known as a glucagon-like peptide-1 receptor agonist
Weight loss typically accelerates as the dose is gradually increased over 16 weeks to the maintenance dose of 2.4 mg weekly for weight management
In 2006, Competitive Technologies, a technology transfer company operating on behalf of the University of Arizona, licensed the drug as a tanning agent
Lifestyle interventions were the least effective treatment, the investigators found, producing a mean total body weight loss of 7.4% at the end of the treatment period, followed by a mean per-month weight regain of 0.14%, with participants reaching their pre-intervention weights within 4.1 years